Received Mar 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| CHIK | CHIKUNGUNYA LIVE (IXCHIQ) | VALNEVA USA, INC. | UNK | — | SYR / RA |
| TYP | TYPHOID VI POLYSACCHARIDE (TYPHIM VI) | SANOFI PASTEUR | UNK | — | SYR |
| YF | YELLOW FEVER (STAMARIL) | SANOFI PASTEUR | UNK | — | SYR / LA |
Experienced high fever (103) with chills that were not relieved much by ibuprofen for 7 days. After around 3-5 days fever-free, joint pain in the knees, ankles, wrists, and PIP joints similar to the symptoms of chikungunya persisted. Acute joint pain is still being experienced 5 months later. Leading theory from rheumatologist is that the vaccine predisposed the patient (me) to an autoimmune condition. Patient has been on and off prednisone, and is now seeking treatment using methotrexate and hydroxychloroquine to find relief.
no known illnesses
no previous chronic conditions.
escitalopram, 20mg
no allergies
December 6, 2024: C reactive protein was 29.3, rheumatoid factor was <10, CBC with auto differential showed all normal results, erythrocyte sediment rate (ESR) was 28. February 6, 2024, after a week off of prednisone, C-reactive protein was <3.0, rheumatoid factor was <10, Complement C4 was 9, Compliment C3 was 116, ANA Screen IFA was positive, ANA titer was 1:320 (high), and the ANA pattern was nuclear, speckled. Double stranded DNA antibody was 4, Scl-70 antibody was <1.0 NEG, and RNP was <1.0 NEG.